tiprankstipranks
Trending News
More News >
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Cash flow

Compare
97 Followers

Design Therapeutics Cash Flow

DSGN's free cash flow for Q3 2025 was $-11.16M. For the 2025 fiscal year, DSGN's free cash flow was decreased by $15.37M and operating cash flow was $-11.16M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -43.10M$ -58.56M$ -51.32M$ -29.38M$ -8.67M
Investing Cash Flow
$ 43.95M$ 52.54M$ -220.99M$ -53.64M$ -33.56M
Financing Cash Flow
$ 513.00K$ 724.00K$ 235.00K$ 379.21M$ 44.53M
End Cash Position
$ 22.56M$ 21.20M$ 26.50M$ 298.57M$ 2.38M
Free Cash Flow
$ -43.45M$ -58.82M$ -52.23M$ -30.91M$ -8.74M
Currency in USD

Design Therapeutics Cash Flow